Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · Real-Time Price · USD
19.83
-1.18 (-5.62%)
At close: Mar 3, 2026, 4:00 PM EST
20.34
+0.51 (2.57%)
After-hours: Mar 3, 2026, 7:01 PM EST

Amphastar Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9001,2311,7852,9631,3541,114
Market Cap Growth
-41.05%-31.07%-39.75%118.80%21.52%16.65%
Enterprise Value
1,2731,6112,1653,3361,2731,106
Last Close Price
19.8326.7837.1361.8528.0223.29
PE Ratio
9.7712.5511.1921.5414.8217.94
Forward PE
5.997.789.4220.7716.2916.96
PS Ratio
1.251.712.444.602.712.55
PB Ratio
1.151.562.444.632.562.50
P/TBV Ratio
4.045.5212.60113.422.762.74
P/FCF Ratio
7.4210.1510.3620.3920.7915.80
P/OCF Ratio
5.767.888.3716.1515.1911.37
PEG Ratio
1.427.010.990.920.860.89
EV/Sales Ratio
1.772.242.965.182.552.53
EV/EBITDA Ratio
5.787.328.3814.039.6311.65
EV/EBIT Ratio
7.799.8510.5416.7011.8515.43
EV/FCF Ratio
10.5013.2912.5622.9519.5515.68
Debt / Equity Ratio
0.830.830.890.980.190.24
Debt / EBITDA Ratio
2.852.852.462.560.751.05
Debt / FCF Ratio
5.415.413.784.291.581.48
Net Debt / Equity Ratio
0.470.470.590.57-0.14-0.07
Net Debt / EBITDA Ratio
1.701.701.661.54-0.55-0.34
Net Debt / FCF Ratio
3.083.082.492.52-1.12-0.45
Asset Turnover
0.450.450.470.570.710.67
Inventory Turnover
2.202.202.762.782.552.51
Quick Ratio
2.802.802.071.652.792.08
Current Ratio
4.024.023.072.173.993.06
Return on Equity (ROE)
12.90%12.90%23.26%23.55%18.76%14.16%
Return on Assets (ROA)
6.37%6.37%8.31%11.07%9.51%6.88%
Return on Invested Capital (ROIC)
11.19%11.17%15.98%22.19%19.68%13.13%
Return on Capital Employed (ROCE)
11.10%11.10%14.60%15.50%16.60%12.60%
Earnings Yield
10.90%7.97%8.94%4.64%6.75%5.57%
FCF Yield
13.47%9.85%9.65%4.91%4.81%6.33%
Buyback Yield / Dilution
7.38%7.38%1.78%-1.09%-5.31%-1.34%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q